Home › Ocular Hypertension › California
Ocular Hypertension clinical trials in California
3 studies for Ocular Hypertension are looking for participants at sites in California.
A Study to Evaluate Efficacy and Safety of YSBP Compared to Lumigan in Patients With Glaucoma or Ocular Hypertension
- National Clinical Trials, Beverly Hills
- United medical research institute, Inglewood
- Eye research foundation, Inc., Newport Beach
- and 2 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 23, 2026 · NCT07661329Clarifying the Optimal Application of SLT Therapy Trial
- Harvard Eye Associates, Laguna Hills
- Doheny Eye Center UCLA, Pasadena
- University of California, Davis, Sacramento
- and 1 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Aug 14, 2026 · NCT04967989Bioequivalence Study With Clinical Endpoint Comparing Bimatoprost Ophthalmic Solution 0.01% and LUMIGAN® in the Treatment of Chronic Open-Angle Glaucoma or Ocular Hypertension in Both Eyes.
- Eye Research Foundation Inc., Newport Beach
- North Bay Eye Associates, Inc., Petaluma
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Aug 10, 2022 · NCT05401357From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.